A Comprehensive Guide to Toxicology in Nonclinical Drug Development
3rd Edition
Elsevier Science · Print & ebook · February 27, 2024
We earn from qualifying purchases.
- Who it’s for
- Coverage spans nonclinical toxicology topics across small molecules, biologics, and drug development.
- Genres
- Toxicology, Pharmacology, Pharmaceutical Technology
- Published
- Elsevier Science, February 27, 2024
Nearest books
Matched by what the books are about, then ordered by what their readers also loved. Most of these share its genre: Toxicology.
The Dose Makes the PoisonPatricia Frank, M. Alice Ottoboni75% match
Basic Principles of Drug Discovery and DevelopmentBenjamin E. Blass, Benjamin Blass74% matchAlso shares Pharmacology and Pharmaceutical Technology
A Practical Guide to Toxicology and Human Health Risk AssessmentLaura Robinson71% match
Principles of ToxicologyStephen M. Roberts, Robert C. James69% match
Drug-like PropertiesLi Di, Edward H Kerns66% matchAlso shares Pharmacology and Pharmaceutical Technology
Essentials of ToxicologyBraylon Holden62% match
Environmental ToxicologyMohd. Salim Reshi, Darakhshan Javaid62% match
Essentials of ToxicologyJaenette Mountford60% matchAlso shares Pharmacology
Start with three books, and this one can be the first.
Members get a new edition every morning: a route out from their books to essays, research and talks, with the reason for each.
Start with this bookAbout this book
A Comprehensive Guide to Toxicology in Nonclinical Drug Development, Third Edition is a valuable reference providing a complete understanding of all aspects of nonclinical toxicology in pharmaceutical research. This updated edition has been expanded and re-developed covering a wide-range of toxicological issues in small molecules and biologics. Topics include ADME in drug discovery, pharmacokinetics, toxicokinetics, formulations, and genetic toxicology testing.
Continue reading
The book has been thoroughly updated throughout to reflect the latest scientific advances and includes new information on antiviral drugs, anti-diabetic drugs, immunotherapy, and a discussion on post-pandemic drug development challenges and opportunities. This is an essential and practical resource for all toxicologists involved in nonclinical testing in industry, academic, and regulatory settings. - Provides updated, unique content not covered in one comprehensive resource, including chapters on stem cells, antiviral drugs, anti-diabetic drugs, and immunotherapy - Includes the latest international guidelines for nonclinical toxicology in both small and large molecules - Incorporates practical examples in order to illustrate day-to-day activities and expectations associated with working in nonclinical toxicology
Nonclinical Toxicology
Coverage spans nonclinical toxicology topics across small molecules, biologics, and drug development.
Come here for
- ADME, pharmacokinetics, toxicokinetics, formulations, and genetic toxicology testing
- Coverage of stem cells, antiviral drugs, anti-diabetic drugs, and immunotherapy
Expect
- International guidelines for nonclinical toxicology in small and large molecules
- Practical examples of day-to-day activities and expectations in nonclinical toxicology
Where it sits
| Toxicology | 95% |
|---|---|
| Pharmacology | 49% |
| Pharmaceutical Technology | 36% |
Percentages are BookFrontier’s reading of the book.
Publisher categories
- Pharmacology
- Authors
- Ali S. Faqi DVM PhD DABT ATS, Ali S. Faqi
- Publisher
- Elsevier Science
- Published
- February 27, 2024
- Format
- Print & ebook
- Reading lane
- Pharmacology